OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10M NIH contract to develop new vaccine adjuvants
October 20, 2014
Oregon Health & Science University's Vaccine & Gene Therapy Institute (OHSU) has been awarded a $10 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Kineta, Inc., ...

